The invention relates inter alia to a method for differentiating a muscle progenitor cell, comprising the step of: culturing a muscle progenitor cell in a serum-free medium for differentiating a muscle progenitor cell, wherein said serum-free medium comprises at least one differentiation inducer selected from the group consisting of a lysophosphatidic acid receptor 1 (LPAR1) agonist, a lysophosphatidic acid receptor 3 (LPAR3) agonist, an oxytocin receptor (OXTR) agonist, a glucagon receptor (GCGR) agonist, a lactate and a Notch signaling pathway inhibitor.

An algae cultivation medium includes a growth medium and at least one of an amine additive and a water-soluble biomimetic catalyst. A related method of increasing carbon shuttling in an algae cultivation medium includes adding at least one of the amine additive and the water-soluble biomimetic catalyst to the algae cultivation medium.

A SMAC mimetic and pharmaceutical compositions thereof and methods of use.

Cultivating a pluripotent stem cell in a medium comprising at least one member selected from the group consisting of ethanolamine, an ethanolamine analog, and a pharmaceutically acceptable salt thereof, and which is substantially free of -mercaptoethanol or contains -mercaptoethanol at a concentration of not more than 9 M, and the like, is effective for the proliferation of a pluripotent stem cell while maintaining an undifferentiated state.

The invention relates to an in vitro method of obtaining and culturing primary tumour cells from a tissue sample using an isolation buffer, which includes collagenase II and optionally hyaluronidase and a propagation medium which includes estradiol or EGF. The invention also relates to a kit for obtaining and culturing primary tumour cells.

This invention provides disc stem cells, processes for obtaining and culturing disc stem cells, and methods for repairing damaged or diseased disc tissue comprising the use of the disc stem cells of the invention.

This invention is directed to, inter alia, compounds, methods, systems, and compositions for the maintenance, enhancement, and expansion of hematopoietic stem cells derived from one or more sources of CD34+ cells. Sources of CD34+ cells include bone marrow, cord blood, mobilized peripheral blood, and non-mobilized peripheral blood. Also provided herein are compounds of Formula I

##STR00001##

which are useful in maintaining, enhancing, and expanding of hematopoietic stem cells.

The present invention relates to cell culture media compositions comprising deep eutectic solvents and/or ionic liquids.

The present invention provides a new method for producing Engineered Heart Muscle (EHM) under chemically fully defined conditions all compatible with GMP regulations. The resulting human myocardium generates force and shows typical heart muscle properties.

The present invention relates to a method of converting human fibroblasts into neural stem cells, and more particularly, to a method of directly converting human fibroblasts into neural stem cells using only a combination of small-molecule compounds without any introduction of a foreign gene, and to the use of the neural stem cells. The method of directly converting human fibroblasts into neural stem cells using only small-molecule compounds without any introduction of a foreign gene makes it possible to obtain genetically stable neural stem cells in an amount sufficient for use in cell therapy by deriving them from human fibroblasts. The neural stem cells obtained according to the method of the present invention can differentiate into functional neural cells and are not tumorigenic. Thus, these neural stem cells are useful as cellular therapeutic agents for treatment of brain diseases.